You have always posted knowledgably about MS, and I remember years ago having to consistently correct your assertions that Rituxan was going to succeed first in RRMS and later in PPMS.
So instead of your constant gratuituous self-congratulations every time a PMl case comes up, why didnt you latch on to my posts on OPXA's Tovaxin data ?
Look at this, OPXA is now a 50-bagger after hitting $7 yesterday.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=40461598
And what is more, you are wasting your time with Tysabri, it will persevere despite your and Dew's irrelevant contempt for all-things Elan.
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM